You are here

Gilead

Gilead doubles down on HIV prevention, treatment amid Covid setbacks and awaiting FDA decision on long-acting candidate

Endpoints

Thu, 07/21/22 - 09:46 pm

COVID-19 drug remdesivir recommended for EU approval

Pharmaforum

Fri, 06/26/20 - 09:43 am

Which Big Pharma Stocks Lose Most in a War on Drug Price Hikes?

Yahoo/Motley Fool

Sun, 01/20/19 - 03:20 pm

ASH: Gilead, Novartis tout long-term data for CAR-T slow starters Yescarta, Kymriah

Fierce Pharma

Sun, 12/2/18 - 11:01 pm

Gilead to Launch Authorized Generic Versions of Epclusa and Harvoni for Chronic Hepatitis C

Mon, 09/24/18 - 09:22 am

FDA calls out 39 drug companies for allegedly blocking access to generics

Stat

Thu, 05/17/18 - 10:15 am

Valeant Pharmaceuticals

HIV Patients File Class Action and Personal Injury Lawsuits for California Patients Against Gilead

Wed, 05/9/18 - 09:23 am

Gilead and Alphabet's Verily to Collaborate on Research in Immunological and Molecular Drivers of Inflammatory Diseases

Mon, 04/30/18 - 05:38 pm

Gilead Presents Data on Multiple Investigational Regimens for the Treatment of Patients With Nonalcoholic Steatohepatitis (NASH) and Advanced Fibrosis

Fri, 04/13/18 - 12:10 pm

J&J lines up its 4-in-1 HIV pill for FDA behind rivals from Gilead, GSK

Endpoints

Mon, 09/25/17 - 09:44 am

Big Biotech is here — and it’s starting to look a lot like Big Pharma

Stat

Mon, 06/6/16 - 10:48 am

Patent Troubles Hit Biogen After Gilead, Regeneron; What’s Next?

Bidness, ETC

Fri, 03/25/16 - 09:39 am

Will Merck Encroach On Gilead's Harvoni Territory?

Yahoo/Benzinga

Tue, 02/23/16 - 05:44 pm

AbbVie Not Worried About Humira Biosimilars

Bidness, ETC

Mon, 09/21/15 - 10:54 am

Gilead combo drug fights all forms of hep C infection: data

Yahoo/Reuters

Mon, 09/21/15 - 10:51 am

Will Gilead Sciences (GILD) Stock Fall on Fewer Hep-C Prescriptions?

TheStreet.com

Fri, 09/11/15 - 05:54 pm

Gilead Sciences Ready To Face Complera Patent War With Mylan

Bidness, ETC

Thu, 09/10/15 - 10:17 am

Gilead banks $10B, stirring fresh buzz about a blockbuster buyout

Fierce Biotech

Thu, 09/10/15 - 10:04 am

Why Gilead's hep C scripts are slowing down in Q3

BioPharma Dive

Wed, 08/26/15 - 10:44 am

Analysts: Gilead's hep C scripts keep slowing, and Q3 sales forecasts should too

Fierce Pharma

Mon, 08/24/15 - 12:00 pm

Pages